Prescription Drug Price Reporting Act
United States116th CongressHR-5239House of Representatives
Updated: Nov 22, 2019
Summary
Prescription Drug Price Reporting Act This bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance. HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-1664: Prescription Drug Price Reporting ActRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in House
Referred to the House Committee on Energy and Commerce.
House of Representatives
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.